Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety profile of NMS-1116354, a CDC7 kinase
inhibitor, in adult patients with advanced/metastatic solid tumors.